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Abstract
Many studies have shown an association between both surgeon and hospital operative procedure volumes and outcomes,
particularly operative mortality. It is also recognized that volume is only one of a number of factors, including 1) surgeon
training and experience, and 2) hospital resources, organization, and processes of care, which can also influence outcomes.
The Surgical Oncology Program at Cancer Care Ontario has included hospital volumes in a set of standards for the conduct
of major pancreatic cancer surgery, along with recommendations for surgeon training and hospital resources, organization,
support services, and processes of care to encourage regionalization of major HPB surgery. Cooperation with these
recommendations was encouraged by the public reporting of mortality data and by an educational program directed at both
surgeons and senior administrators in Ontario hospitals with the support of the provincial health ministry. The provincial
mortality rate from major pancreatic cancer surgery has decreased by more than 50% since the introduction of this program.
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Background
The association between case volume and improved
outcomes is playing an increasing role as an indicator
of the quality of surgical practice in a variety of
settings. This association has been studied between
both surgeon and hospital operative procedure vo-
lumes and a range of outcomes including operative
mortality, complication rates, hospital costs, and long-
term survival [1,2]. Most of these studies have shown
a positive relationship between increasing volume and
better outcomes, although there are exceptions. The
most consistent relationship has been demonstrated
between volume and postoperative mortality. The
association is stronger for hospital than for surgeon
volume, and the most consistent relationship is seen
for operations that are complex and carry high risk.
Although there are extensive data supporting this
volume outcome relationship, there are some limita-
tions to the conclusions that can be drawn from these
data. There are numerous individual hospitals and
surgeons that are exceptions to the usual pattern,
many of the quoted publications refer to hospital data
that may not represent current practice, and there is
wide variation in the type of risk adjustment, if any,
that was used in many of the reported studies.
A common problem in the existing reports is that
the highest volume category reported tends to under-
estimate the actual procedure volumes, since that
category is open ended and its reference point is the
lowest volume in the range. This can be particularly
problematic when these data are used to estimate
volume thresholds that are being recommended to
achieve desired outcomes. Table I shows the volume
thresholds and corresponding actual mean numbers
of cases per year in the highest volume range in eight
hospital volume outcome studies that examined
the relationship of postoperative mortality to case
volume following major pancreatic resection [1,39].
The actual mean number of cases per year in the
highest volume category in these studies varied from
1.2 to 5.0 times the volume threshold reported. Since
the data in the literature suggest that the volume
outcome relationship tends to be consistent over a
wide range of volumes, it is more likely that good
outcomes observed in these high volume ranges are
related to the mean volumes observed than to the
threshold volumes for the highest volume categories.
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This has not been considered in the past when
recommendations have been made regarding volume
thresholds being established for quality improvement
purposes.
It is also generally agreed now that volume alone is
not enough to explain variation in outcomes between
hospitals or between surgeons. There are many other
factors that can contribute to improved outcomes that
have been observed to be associated with increased
volumes. These can be classified as factors that are
either related to surgeons themselves or to the systems
in which surgeons work. At the surgeon level, the
intuitive hypothesis is that ‘practice makes perfect’;
however, any occasional golfer can testify that practice
alone is not enough reach a high level of performance.
A more appropriate version of that hypothesis might
be ‘perfect practice makes perfect’, which fits better
with the modern concepts of surgical training, includ-
ing supervision, performance standards, objective
feedback, and subjective self-assessment. In addition
to the effects of training and mentoring, there are
other considerations including natural ability and
motivation that may play an important role in
determining surgeon performance, but these are
much more difficult to measure.
When considering the role of the system in which a
surgeon works, one can examine both its structure
and its processes of care. Structure includes physical
and human resources necessary to carry out the
specific service required. These include things like
diagnostic imaging, pathology, OR and ICU capabil-
ity, and the support of other medical and related
specialists who are also trained to a high level of
competence. Sufficient numbers of patients (volume)
to develop and maintain the expertise required of all
the involved health care workers is just one of the
structural elements that can contribute to good out-
comes.
Processes of care are the wide variety of transac-
tions  both complex and simple  between a patient
and healthcare providers, between different providers,
and between a patient and his/her health care envir-
onment. These interactions may be provider planned
and initiated, spontaneous, accidental, protocol- and
evidence-based, or completely idiosyncratic. Because
modern health care is so complex, with so many
interactions occurring in an individual patient, the
opportunity for error is high, and the need for system
design around evidence-informed processes of care is
paramount. Quality improvement initiatives need to
include a careful examination of all relevant processes
of care in addition to structural and training issues to
be successful.
Volume alone is just a surrogate predictor of quality,
but from the evidence, it is a pretty good surrogate,
and has the benefit of being easily measurable. The
relationship of volume to performance has achieved
sufficient credibility to be used in the marketing of
health services, and as a requirement for preferred
provider status, for example by the Leapfrog Group in
the United States [10]. Case volume, expressed as
population served, has also been used as a require-
ment in regional health service planning for HPB
surgery by the National Health Service in the UK
[11].
This paper will outline how procedure volume is
being used as part of a process of quality improvement
in surgery in the province of Ontario, Canada, along
with a number of other elements including surgeon
training and experience, hospital structure and pro-
cesses of care, and regional and provincial planning
and policy making.
Quality improvement in cancer surgery in
Ontario
Cancer Care Ontario (CCO) is the provincial agency
responsible for cancer services for a population of
12.5 million people in Ontario, Canada. The CCO
Surgical Oncology Program, created in 2001, has
developed a Quality Improvement Program based on
a) development of guidelines and standards; b)
measurement of performance through the use of
indicators which are reported publicly; and c) im-
plementation of QI initiatives using a knowledge
translation strategy based on Communities of Practice
in individual surgical specialties.
Table I. Hospital volume/outcome studies of mortality following pancreas resection.
Highest volume category
Cases per year
Reference Threshold Mean Mortality rate (%)
Edge et al. 1993 [3] 2 8.4 5.1
Lieberman et al. 1995 [4] 10.1 23.4 5.5
Glasgow & Mulvihill 1996 [5] 10 14.3 3.5
Imperato et al. 1996 [6] 6.3 17.2 2.2
Gordon et al. 1998 [7] 20 28 1.8
Sosa et al. 1998 [8] 20 88 0.8
Simunovic et al. 1999 [9] 6 17.2 3.4
Birkmeyer et al. 2001 [10] 16 80.0 3.8
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The overall goal of the Surgical Oncology Program
is to develop a cancer surgery care delivery system
that is of high quality, patient-centered, assessable,
interdisciplinary, and integrated. This is being done
through the development of regional networks of care
in which ‘standard’ care is more widely distributed
and complex or uncommon care will be delivered in
regional or provincial or specialized centers. The
quality expectations are the same whether the centers
are large or small. Patients will thus able to receive
most of their care close to home, but may have to
travel to access high quality complex care.
Public reporting of quality indicators was initiated
in 2004 with the introduction of the Cancer Services
Quality Index [12]. This is a public report on the
Cancer Care Ontario website of 26 indicators cover-
ing the spectrum of cancer prevention, screening,
treatment, and outcomes. Included are surgery-
related indicators such as hospital procedure volumes,
mortality rates, waiting times, utilization rates, lymph
node retrieval, and margins status. Considerable
information is also available to the Surgical Oncology
Program through national and provincial databases to
measure other process and outcomes that may not be
reported publicly.
Volume and outcomes in pancreatic cancer
In 1997 a study of the relationship of hospital volume
and postoperative mortality following radical pancrea-
tic resection (Whipple or total pancreatectomy) was
carried out in Ontario [9]. A preliminary analysis of
the data was in keeping with that from other jurisdic-
tions and showed a provincial mortality rate of 10.2%,
with a higher mortality rate in low volume hospitals
and a lower mortality rate in high volume hospitals.
Because the study had been supported by the Institute
of Clinical Evaluative Sciences, a provincially funded
research body, there was an obligation to make the
data public. However, before this was done, an expert
panel was created to develop a set of standards for the
conduct of major pancreatic surgery so that the
release of this information would be accompanied by
a reassurance to the public that steps were being taken
to correct the problems identified. This expert panel
produced a document entitled ‘Criteria for the
Delivery of Pancreatic Cancer Surgery’, which out-
lined recommendations for: the formal training and
surgeon experience required for the conduct of HPB
surgery, the necessary hospital resources, organiza-
tion, and infrastructure, and for the volumes of both
major pancreatic surgery (at least 10 cases per year)
and total HPB surgery (at least 25 cases per year)
considered to be required for optimum outcomes
[13]. A benchmark for postoperative mortality of
B5% was proposed.
The public release of the hospital mortality data
was accompanied by articles in the newspapers and
the expected negative reaction from some hospitals
and surgeons. However, when the standards were
then distributed many hospitals made changes in the
management of pancreatic cancer, including some
that disallowed some or all of the surgeons to do those
operations, and others that reorganized services to
better meet the standards that had been recom-
mended. Strategies for continuing education of sur-
geons included presentations at scientific meetings
and informal contacts through communities of prac-
tice. A qualitative review by questionnaire was carried
out in 2001, and 57 of 92 hospitals responded. One
quarter had made changes to comply with the
recommendations and half of the hospitals reported
that at least one surgeon had stopped doing pancreatic
surgery. A more detailed follow-up was carried out in
2005 and this showed that the number of these cases
that were being treated in hospitals with volumes of 10
or more cases per year had increased from 17.8% in
the early study to 60.8% in the years 20022004. The
provincial 30-day case fatality rate (death in hospital
or within 30 days) had decreased from 10.2% to
4.5%.
Figure 1 shows the redistribution of major pan-
creatic surgery volume between the two time periods
with a reduction in the total number of hospitals
involved from 72 to 28 and a shift in the case volume
from low volume hospitals (B10/year) to medium
(1020/year), and high volume (20/year) hospitals.
Figure 2 shows that in addition to the decrease in the
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Figure 1. Pancreatic resection in Ontario: volume distribution 198896 and 20022004.
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mean mortality rate across the province there was a
decrease in the mortality rates in each of the volume
categories. This is in keeping with the hypothesis that
there were other factors involved in the overall
improvement in outcomes in pancreatic surgery in
addition to case volumes. Our assumption is that
more attention was paid to the surgeon training and
hospital structural and processes of care based on the
new standards, and that public disclosure played an
important role in motivating these changes. These
changes in Ontario were unique to pancreatic cancer
surgery. For example, standards for esophageal cancer
surgery had not yet been developed nor had there
been public disclosure of esophageal operative mor-
tality rates. The remarkable decrease observed in the
mortality rate from pancreatic surgery during this
time period did not occur with esophageal surgery.
There were also efforts made in the Netherlands
(population about 15.5 million) at about the same
time to deal with the excess mortality from pancreatic
cancer surgery in low volume hospitals [14]. In a
study of pancreatic resections from 1994 to 1998 the
national postoperative mortality was reported as
10.7%, with a death rate of 16% in the lowest volume
institutions and 1% in the highest. These data were
presented at multiple meetings of surgeons in the
Netherlands over the next few years. In a follow-up
study reported in 2006 [15], the mortality rates and
variation between low and high volumes hospitals in
20012003 remained essentially unchanged from the
previous study. There was also little change in the
proportion of patients being operated on in low
volume institutions. One can speculate about various
reasons for the current differences in case distribution
and mortality between Ontario and the Netherlands,
but the proactive approach of standard development
and promotion along with public reporting of mor-
tality outcomes would seem to be likely candidates.
Because almost 40% of the pancreatic cases in
Ontario were still being treated in hospitals with
volumes less than 10 cases per year, another expert
panel was convened to review and update the pan-
creatic standards, this time expanding the scope to all
HPB surgery. The resulting document entitled ‘He-
patic, Pancreatic and Biliary (HPB) Surgical Oncol-
ogy Standards’ was completed in June 2006 and is
available on the Cancer Care Ontario website [16].
The surgeon and hospital requirements were similar
to the previous set of standards except for a more
explicit accountability requirement in the recom-
mended administrative structure of a HPB service.
The volume targets were increased to at least 20 major
pancreatic and a total of 50 major HPB cases per year.
These volumes would serve a population of approxi-
mately one million people based on current levels of
activity. The benchmark operative mortality for pan-
creatic resection was left at B5% and for anatomical
liver resection was set at B3%. This document along
with a similar set of standards for thoracic cancer
surgery and for multidisciplinary cancer conferences
is currently being used to inform the planning process
being carried out by new regional health authorities
that have been established by the Ontario govern-
ment. Additional cancer surgery standards and guide-
lines are currently being developed in CCO by the
Surgical Oncology Program along with the Program
in Evidenced Based Care [17].
Conclusion
Hospital and surgeon case volumes are among a
number of factors that can influence outcomes
following major surgical procedures and can contri-
bute to quality improvement in cancer surgery. A
quality improvement program was implemented in
the Province of Ontario that included the initiatives
of: public reporting of postoperative mortality in
pancreatic surgery, the dissemination of a set of
standards for the delivery of such surgery, including
recommendations for surgeon training, hospital re-
sources and organization, and minimum volume
requirements. Regionalization of complex services
was encouraged by the provincial cancer agency and
promoted through continuing education of practicing
surgeons using formal presentations and informal
mechanisms including Communities of Practice.
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Figure 2. Pancreatic resection in Ontario: mortality rates 198896 and 20022004.
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These initiatives were associated with a reduction in
the total number of hospitals doing pancreatic sur-
gery, a shift in cases from low to higher volume
hospitals and a decrease in both overall provincial
mortality rates and mortality rates within each of the
volume categories. It is our belief that the change in
outcomes was the result of all of these initiatives
together rather than any of them independently, and
this coordinated systematic provincial quality im-
provement strategy is currently being applied in other
disease sites.
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